Lisata Therapeutics
LSTA
26 hedge funds and large institutions have $1.9M invested in Lisata Therapeutics in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.
0.01% more ownership
Funds ownership: 0.53% → 0.54% (+0.01%)
7% less funds holding
Funds holding: 28 → 26 (-2)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
33% less capital invested
Capital invested by funds: $2.85M → $1.9M (-$952K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$193K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$45.7K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$43.7K |
| 4 |
VF
Virtu Financial
New York
|
+$34.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$64.1K |
| 2 |
STA
Summit Trail Advisors
New York
|
-$64K |
| 3 |
TFO
Tarbox Family Office
Newport Beach,
California
|
-$42K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$12K |
| 5 |
RFC
Regions Financial Corp
Birmingham,
Alabama
|
-$8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CHP
26
Cable Hill Partners
Portland,
Oregon
| – | -$2K | -33 | Closed |
|
27
Simplex Trading
Chicago,
Illinois
| – | +$44 | +1 | New |
|
LSTA Hedge Fund Activity: Q2 2019 in Review
26 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Lisata Therapeutics (LSTA) for Q2 2019, worth a combined $1.9M — down 33% from $2.85M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of LSTA and 3 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, adding an estimated $193K. The largest seller was BlackRock, cutting an estimated $64.1K.
- 26 institutional investors held Lisata Therapeutics (LSTA) as of Q2 2019, down from 28 in Q1 2019.
- Funds reported $1.9M of Lisata Therapeutics stock for Q2 2019, down 33% quarter-over-quarter.
- 3 funds opened new Lisata Therapeutics positions in Q2 2019 and 4 closed out, a net change of -1 holder.
- The largest Lisata Therapeutics buyer in Q2 2019 was Renaissance Technologies, an estimated $193K added.
- The largest Lisata Therapeutics seller in Q2 2019 was BlackRock, an estimated $64.1K sold.
Based on aggregated 13F filings for Q2 2019.